newsfilter
← Latest News
GlobeNewswire·

SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update

Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K Launched Sales of Arbli™, the First FDA-Approved Ready-To-Use Liquid Formulation of Losartan for Hypertension